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Inadequate preparation of prostate cancer patients undergoing radiation therapy (RT) can 
damage healthy tissue and cause long-term complications. Proper setup can reduce side 
effects. Currently, there are no standardized guidelines to help prepare patients for 
prostate radiation. Guidelines will help nurses coordinate care and manage symptoms for 
these patients. The purpose of this doctoral project was to address the gap in practice of 
the lack of a standardized process for implementing presimulation interventions for 
patients with prostate cancer undergoing RT by developing an evidence-based clinical 
practice guideline (CPG). The practice question for this project focused on the best 
practices contributing to a CPG for set up patients with prostate cancer undergoing RT 
treatment. The model guiding the development of a CPG was the Johns Hopkins nursing 
evidence-based practice model. Sources of evidence that informed the CPG came from 
these databases: CINAHL Plus with Full Text, MEDLINE with Full Text, PubMed, Ovid 
Nursing, Embase, ProQuest Nursing and Allied Health Source, and Google Scholar. The 
project team used the Appraisal of Guidelines for Research and Evaluation (AGREE) II 
method to assess for the validity of the CPG. A prostate radiation oncologist, RT director, 
and prostate nurse analyzed the CPG using the AGREE II instrument and indicated 
validity in the CPG for guiding nurses to appropriate interventions. The recommendation 
is to implement a CPG with interventions that address bladder and bowel management, 
image quality, and patient education. The development of CPGs has a potential impact on 
social change by addressing others’ needs, using trustworthy sources for research, and 
developing guidelines that address cultural consideration of the target population.  
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Section 1: Nature of the Project 
Introduction 
Radiation therapy for the treatment of cancer can have toxic effects on both 
cancerous and healthy tissue (Graf, Boehmer, Nadobny, Budach, & Wust, 2012). 
Particular setup can help reduce toxic exposure of radiation to healthy tissue. An 
adequate setup that spares noncancerous tissue can reduce lifelong bowel, bladder, and 
sexual function complications for prostate cancer patients (Tsang & Hoskin, 2017). 
However, there are no clinical practice guidelines (CPGs) for best practice interventions 
for prostate radiation setup at the practice site. With this project, I aimed to determine 
what best practices contribute to a CPG for setting up patients with prostate cancer 
undergoing radiation therapy treatment. CPGs improve care equity, reduce variations in 
care, assist in social change, and define best healthcare practices (Kredo et al., 2016). 
CPGs also allow the nurse to identify barriers and choose more appropriate and 
achievable interventions (Institute of Medicine [IOM], 2011). 
Problem Statement 
The practice problem addressed in this project was the inadequate preparation of 
prostate cancer patients undergoing radiation therapy, starting with the planning of the 
computerized tomography (CT) scan. This scan is required before beginning the 8-week 
radiation treatment (Johns Hopkins Medicine, n.d.). This planning session is referred to 
as a simulation. Patients must understand the importance of adequately preparing for the 





CT scans may be required, resulting in increased radiation exposure for the patient and 
delays in the CT scanner schedule. In the specialty of radiation oncology, proper setup 
and immobilization for treatment are of utmost importance to reduce prostate motion; 
reduced prostate motion has been shown to minimize damage to healthy tissue during 
treatment (Darud, Giddings, Keyes, McGahan, & Tyldesely, 2010). Damaging healthy 
tissue can contribute to short- and long-term side effects caused by the treatment 
(Maggio et al., 2017). Treatment for prostate cancer requires that the patient has a full 
bladder and rectum empty of stool and flatulence (Yaver, 2015). Adequate bowel and 
bladder setup reduces prostate movement during therapy and has been associated with 
improved clinical disease-free survival (Darud et al., 2010; Maggio et al., 2017).  
The first opportunity patients have to experience this setup is during the 
simulation appointment. Simulation for radiation therapy treatment is a nondiagnostic 
CT scan for planning purposes where the patient is positioned like the patient is getting 
radiation treatment (Johns Hopkins Medicine, n.d.). These patients must duplicate this 
alignment preparation every day, 5 days a week, for 8 weeks (Memorial Sloan Kettering 
Cancer Center, n.d.). Due to the combination of the difficulty of obtaining a full bladder 
and an empty rectum and the importance of this setup, patients often do not obtain the 
correct setup during simulation (Maggio el at., 2017). When patients cannot adequately 
set up, they need to be resimulated, which consists of an extra CT scan and, therefore, 
additional radiation to healthy tissues. The waiting period can be uncomfortable for the 





their first scan, which requires them to spend a significant amount of time in the clinic 
awaiting resimulation.  
At the project site, there are currently no CPGs for prostate cancer presimulation 
interventions. In this project, I addressed this gap through the creation of a CPG for use 
at the clinic. In this setting, nurses are responsible for educating patients regarding 
radiation treatment and initiating interventions, such as bowel and bladder preparation 
regimen, for preparing the patient for successful simulation. Developing a CPG can help 
support nurses to prepare the patient better to implement these interventions. 
Purpose Statement 
The purpose of this doctoral project was to address the gap in practice related to 
the lack of a standardized process for implementing presimulation interventions for 
patients with prostate cancer undergoing radiation therapy by developing an evidence-
based CPG. The practice problem addressed in this project was the inadequate 
preparation of prostate cancer patients undergoing radiation therapy for their planning CT 
scan. The guiding practice-focused question for this doctoral project was: What best 
practices contribute to a CPG for preparing patients with prostate cancer undergoing 
radiation therapy treatment? I intended this doctoral project to address the gap in practice 
by evaluating the quality of literature currently available on interventions to minimize 
prostate movement and reduce radiation to healthy surrounding tissue and practically 





Nature of the Doctoral Project 
CPGs are statements developed to optimize patient care informed by a systematic 
review of the evidence (Kredo et al., 2016). A panel of experts and key stakeholders 
should be involved in developing CPGs (IOM, 2011). For this project, I used peer-
reviewed articles involving experimental and observational studies and systematic 
reviews, expert opinion, and publically available patient education materials from 
National Cancer Institute-designated organizations for the past 5 years. I obtained these 
resources by searching databases, including CINAHL, MEDLine, Embase, and ProQuest. 
Additionally, Google Scholar was searched for other resources. I consulted with prostate-
specialized radiation oncologists and included them in the project team to obtain expert 
opinions. The Johns Hopkins nursing evidence-based practice (JHNEBP) model was used 
to grade the evidence and associated tools to synthesize and organize the evidence. Once 
the CPG was developed, it was appraised by the project team using the Appraisal of 
Guidelines for Research and Evaluation (AGREE) II instrument to verify that the 
guidelines were methodologically rigorous and free of bias. The project team determined 
how the guideline needed revision and then presented it to stakeholders. This process 
enabled the doctoral project to fulfill its purpose and fill the gap in practice involving the 
lack of clinical guidelines for prostate cancer presimulation interventions.  
Significance 
 The impact of patients being inadequately prepared for simulation reaches across 





CT scans, and be delayed until later in the day. Nurses are impacted by the lack of 
standardized presimulation interventions and are searching for different techniques to 
best help patients with issues involving the need to be frequently reeducated. Radiation 
therapists must rearrange the machine schedule when patients are delayed due to 
inadequate preparation. Front desk staff are affected by apologizing and attempting to 
preserve customer satisfaction for other patients still awaiting their now delayed 
treatments. Radiation oncologists may face backlash from staff and patients because of 
the frustration with the process.  
Besides having a direct impact on the local clinic, the development of a CPG for 
patients undergoing prostate radiation can contribute to nursing practice by reinforcing 
the concept that nurses can practice to their fullest scope by coordinating care and 
symptom management. Nurses may find this guideline beneficial in acting as the 
multidisciplinary leader in ensuring patients have various interventions to improve 
outcomes. Furthermore, the project team’s findings in the doctoral project can expand the 
base of professional nursing knowledge.  
The development of this CPG has the potential for transferability to other 
practices outside of the project site clinic. The guidelines can be locally transferred to 
other clinics within the health system for patients with prostate cancer. On the Oncology 
Nursing Society discussion board (https://communities.ons.org/), the topic of bowel and 
bladder preparation comes up frequently. Within the United States, there are no societal 





undergoing prostate radiation therapy, so there is potential for national transferability as 
well. The Global Cancer Observatory (2018) reported that prostate cancer is the second 
most common cancer in men globally and is expected to increase in prevalence over the 
next 2 decades. While the guidelines may recommend interventions or techniques that are 
not currently available everywhere globally, there is great potential for international 
transferability for most clinical guidelines. Especially in areas where imaging technology 
is not as advanced, it is important to reduce prostate motion; reducing prostate motion 
can spare healthy tissue and improve mortality (den Harder, van Gils, Kotte, van Vulpen, 
, & Lips, 2014). 
Developing CPGs has potential implications for positive social change by 
establishing evidence-based interventions in an easy-to-use format for use in small, 
generalized radiation clinics and large, highly specialized academic institutions. 
Additionally, this project aligns with Walden University’s (2017) mission for social 
change by addressing others’ needs, using trustworthy sources for research, and 
developing inclusive guidelines that address cultural consideration of the target 
population. 
Summary 
Undergoing cancer treatment can be frightening and anxiety-producing for 
patients; therefore, patients must trust the healthcare team to provide the best treatment. 
However, finding the best evidence-based practices (EBPs) can be time-consuming and 





evidence-based interventions for specific situations. In Section 1, I described the gap in 
practice and project question, the nature of the project, and the significance of the project 
to stakeholders. In Section 2, I will introduce the model that framed the project, the 





Section 2: Background and Context 
Introduction 
Preparing patients undergoing radiation oncology to set up the same way every 
day for treatment is important to ensure they receive the planned radiation to cancerous 
tissue. This setup can be obtained with special pillows, masks, and surgical interventions 
(Memorial Sloan Kettering Cancer Center, n.d.). Patients receiving radiation for prostate 
cancer have a challenging setup; they must have an empty rectum and a full bladder, and 
often, they struggle with or cannot obtain an appropriate setup for treatment (Maggio et 
al., 2017). 
The practice problem addressed in this project was the inadequate preparation of 
prostate cancer patients undergoing radiation therapy for the planning session. There are 
no standardized procedures to guide staff to help prepare the patients for setup. Through 
this project, I sought to identify evidence to support the development of a CPG for 
presimulation preparation for patients with prostate cancer undergoing radiation therapy. 
Identifying the information and developing a CPG addressed the gap in practice 
involving the lack of a standardized process for implementing presimulation interventions 
for prostate cancer patients undergoing radiation therapy. In this section, I review the 
following related to the development of CPGs: guiding theories and models, relevance to 





Concepts, Models, and Theories 
Healthcare providers are tasked with giving patients the best care; unfortunately, 
providers do not always have quick access to evidence-based guidelines that support that 
goal. CPGs are evidence-based references for healthcare providers. According to Jeffs et 
al. (2013), nurses prefer to receive evidence-based information presented in an easy-to-
understand and succinct format. Jeffs et al. identified three factors necessary to address 
when presenting evidence-based interventions to nurses: (a) the information needs to be 
easy to take in, (b) specific to the population/care provided by the staff, and (c) come 
from substantial sources.  
The model used to guide the development of the CPG for this project was the 
JHNEBP model. The JHNEBP model is used to evaluate the level and quality of each 
evidence source, summarize the evidence, and then synthesize the collective evidence for 
quality and strength (Dearholt & Dang, 2012). One benefit of using the JHNEBP model 
is the inclusion of internal and external forces (i.e., regulatory and accreditation bodies) 
when considering the application of identified best practices. The model also supports 
users through problem identification, gathering evidence, and translating into practice 
(Dearholt & Dang, 2012). The first 10 steps of the JHNEBP model are applicable to the 
CPG development process: 
1. Recruit interprofessional team. 
2. Develop and refine the EBP question.  





4. Determine responsibility for project leadership. 
5. Schedule team meetings. 
6. Conduct internal and external searches for evidence. 
7. Appraise the level and quality of each piece of evidence. 
8. Summarize the individual evidence. 
9. Synthesize overall strength and quality of evidence. 
10. Develop recommendations for change based on evidence synthesis (Dearholt 
& Dang, 2012, p. 226). 
Steps 11–18 focus on the translation of evidence into practice and dissemination of 
findings (Dearholt & Dang, 2012). 
Relevance to Nursing Practice 
While large professional organizations like the American Society for Radiation 
Oncology have not developed CPGs for bowel and bladder regimens for prostate cancer 
patients, there is evidence in the literature for independent interventions for simulation 
preparation. Waddle et al. (2018) presented bladder regimen filling recommendations 
that focused on the importance of extra counseling for patients older than 70 years old. 
Yahya et al. (2013) compared dietary guidelines, microenemas, and no preparation and 
found microenemas were significantly (p < 0.001) superior to reduce prostate motion 
during treatment. Darud et al. (2010) found no significance in prostate motion between a 
full bladder with an empty rectum protocol and a full bladder with no specified rectum 





the placement of fiducials (i.e., invasively placed gold markers that are used to indicate 
the location of the prostate on imaging scans) compared to skin marks for reducing 
prostate movement. Additional sources of evidence include expert recommendations 
found in patient education materials from large cancer centers, such as Memorial Sloan 
Kettering Comprehensive Cancer Center (n.d.), which recommended using psyllium 7 
days before simulation and a Fleet enema 3 hours before simulation. Additionally, Rogel 
Cancer Center (2017) recommended bladder filling by voiding 1 hour before the 
simulation appointment and drinking two and a half cups of water. The amount and 
variation of evidence indicate that radiation oncology specialists continue to search for 
presimulation interventions for patients undergoing radiation treatment for prostate 
cancer.   
Medves et al. (2010) identified that CPGs are a way to improve overall care as 
evidenced by improved patient outcomes, patient care, staff satisfaction, and cost-
effectiveness. The IOM (2011) reported that CPGs are useful in specialized areas as 
recommendations but not as rules. Currently, there are no published guidelines on 
interventions to help patients with prostate cancer prepare for simulation. Because the 
providers do not write orders for the bladder and bowel protocol, nurses are left to 
attempt trial and error to help patients prepare based on experience.. Boehmer et al. 






Nurses in radiation therapy maintain responsibility for helping patients prepare for 
treatment. For patients with prostate cancer, the nurse provides presimulation 
interventions to help reduce prostate movement and, therefore, toxicity during and after 
treatment. Boehmer et al. (2006) identified several dosimetric guidelines to reduce the 
irradiation of healthy tissue but could not provide guidelines on bowel and bladder 
regimens to reduce toxicity. Since Boehmer et al.’s guidelines were published, more 
studies have been conducted to identify the appropriateness of individual interventions. 
For example, there are several studies assessing bladder filling protocol. Most of the 
studies are aimed at identifying the appropriate volume of fluid to consume to obtain a 
full bladder (e.g., Braide et al., 2019; Maggio et al., 2017; Nathoo et al., 2018), but Tsang 
and Hoskin (2017) identified that there was no statistically significant difference for acute 
and intermediate toxicities in terms of empty and full bladders for prostate radiation. To 
develop a CPG for this project, I collated these individual recommendations into one 
easy-to-navigate document for radiation oncology nurses.  
Local Background and Context 
Evidence from the project site that supports the relevance of the problem at the 
local level manifests as delays in schedules due to inappropriate preparation for 
simulation, patient-reported qualitative comments obtained from the online patient 
satisfaction survey, and nurse displeasure at the situation taken from the employee 





the lack of standardized guidelines for prepping patients for prostate radiation therapy as 
evidence of not having the tools required to complete the job.  
The identified setting for this project site was the radiation oncology department 
of a large academic health system in a sizeable metropolitan area in the northeast United 
States. This department encompasses six clinics, including four hospital-based and two 
satellite campuses. This project was completed in one of the hospital-based clinics that 
manages the majority of the patients with prostate cancer. This clinic supports a hospital 
that meets the local urban community’s needs and is a destination hospital for national 
and international patients.  
There was support for this project from departmental leadership, prostate 
radiation oncology specialists, and the primary nursing team that supports these patients. 
Stakeholders consisted of prostate radiation oncologists, RNs, a clinical coordinator, a 
clinical nurse specialist, radiation therapists, clinic administration, and patients. Between 
the two full-time prostate care providers at the project site, approximately 32 patients are 
consulted for treatment per month, with about 25 patients actively receiving treatment at 
any given time. Current practice for how patients are educated to prepare for simulation 
varies depending on the radiation oncologist and the nurse consulting the patient. For 
example, one provider recommends that the patient voids 1 hour before simulation then 
sips 32 ounces of water, and another provider tells the patient to void and then drink 
until his bladder is comfortably full. Another variation is the recommended bowel 





psyllium. Practice varies between nursing staff with one of the primary prostate care 
nurses calling patients either the Monday or Wednesday before simulation to review the 
bowel and bladder protocols, while the other hands the protocols to the patient, on a 
sheet of paper, at the time of consultation.  
Role of the DNP Student 
I have been employed by the project site for 3.5 years as the clinical nurse 
specialist in radiation oncology. In my role, I monitor metrics such as patient satisfaction, 
clinic productivity numbers, and safety metrics. I work across all six clinical sites to 
standardize processes, policies, and procedures to improve patient safety and quality of 
care. I am consulted to help with complex patient cases and have been asked by the 
multidisciplinary team to identify best presimulation practices to improve the ability of 
patients with prostate cancer to complete their treatment planning on the first attempt. 
With my training on EBP and project management, I led the project to identify best 
practices and applicability to the project site. I worked with the multidisciplinary team to 
better understand CPG implementation barriers to address these barriers during the CPG 
development process. 
My motivation for this doctoral project came from several factors. First, I was 
concerned about nurse job satisfaction. Our nurses reported in the employee engagement 
survey that they do not have the tools they need to do their job. The primary prostate care 
team nurses have also verbalized dissatisfaction with informing prostate patients on how 





and the nurses are keenly aware that the interventions they are instituting are not evidence 
based. Another motivation for this project was the patients’ quality of life. Patients 
anecdotally report how uncomfortable and challenging it is to maintain a full bladder and 
empty rectum. Patients have even more difficulty maintaining the full bladder when there 
is a delay in the treatment schedule. Delays as short as 15 minutes have resulted in 
episodes of incontinence. Being incontinent can be a mortifying experience for patients 
and further delay that patient’s treatment while the patient’s bladder refills. Finally, I am 
driven by clinic efficiencies. When one patient with prostate cancer is delayed, it creates 
what staff calls a domino effect, and all of the other patients with prostate cancer are 
delayed. When the prostate patients are delayed, they have challenges holding a full 
bladder, often void, and then restart the bladder filling process. My wide-ranging 
motivations led me to want to create the CPG and combat any bias I may have 
contributed to the project, and to mitigate this bias, I selected expert project team 
members to evaluate the CPG using the AGREE II instrument.  
Role of the Project Team 
 The project team was an interdisciplinary team consisting of me, the radiation 
therapy director, a radiation oncology nurse specializing in prostate cancer, and a prostate 
radiation oncologist. I contacted the various team members in person, and they agreed to 
participate in the project. Before the first meeting most of the literature was collected and 
the grading process had started. The team first met to review the literature and grading of 





team to meet weekly, either in person or virtually, to review progress on grading and 
evaluating the literature for recommendations. The group was not able to meet as 
frequently as planned due to the COVID pandemic. At the start of project 
implementation, the team debriefed on the practice problem and current practice at the 
practicum site and were educated on the AGREE II instrument for CPG evaluation. The 
individuals in the group also shared their experiences with the practice problem. They 
provided contextual insight into the challenges surrounding the problem and helped 
identify potential barriers to implementing interventions recommended by the literature.  
Summary 
Previous research on presimulation intervention focuses on individual 
interventions, but there is no evidence in the literature about attempts to combine best 
practices into CPGs for presimulation interventions for patients undergoing radiation 
therapy for prostate cancer. In Section 2, I described how the JHNEBP model can guide 
project teams to collect and synthesize evidence for the development of CPGs. In this 
section, literature was reviewed to highlight the importance of this project to nursing 
practice and the role of the DNP scholar and the project team were described. In Section 






Section 3: Collection and Analysis of Evidence 
Introduction 
The purpose of this doctoral project was to address the gap in practice of the lack 
of a standardized process for implementing presimulation interventions for patients with 
prostate cancer undergoing radiation therapy by developing an evidence-based CPG. 
Kredo et al. (2016) described CPGs as a way to present concise information to improve 
efficiencies and close the gap in practice with available scientific evidence. In the last 5 
years, researchers have identified best practices for individual interventions to improve 
patient setup for simulation for radiation therapy (Tsang & Hoskin, 2017), but no 
guidelines have been developed to recommend a collection of best practices. In this 
section, I review the practice-focused question and the process involved with collecting 
and analyzing evidence sources. 
Practice-Focused Question 
There are no societal or publicly available CPGs for setup for treatments to help 
nurses prepare patients with prostate cancer undergoing radiation therapy. At the 
practicum site, nurses have verbalized frustration at the lack of standardization and 
absence of guidelines for helping patients prepare for prostate radiation therapy. The 
practice question for this project was: What best practices contribute to a CPG for 
preparing patients with prostate cancer undergoing radiation therapy treatment? Moore-
Higgs et al. (2003) reported that since the early 1990s, the radiation oncology nurse’s role 





well as work in close collaboration with the radiation oncologist for 
pharmaceutical/interventional symptom prevention and management. Without standard 
CPGs for presimulation interventions, nurses are challenged to provide consistent, 
evidence-based interventions for these patients. 
Sources of Evidence 
To address the practice-focused question, I collected evidence published within 
the last 5 years. Evidence from expert opinion is not sufficient alone to address the gap in 
practice of the lack of a standardized process for implementing presimulation 
interventions by developing an evidence-based CPG. For this project, I followed the 
guidelines in the Walden University (2019) Manual for Clinical Practice Guideline 
Development. The sources of evidence used included primary sources (i.e., original 
works of evidence obtained through research), translational literature (i.e., CPGs), and 
evidence summaries like systematic reviews (see Dearholt & Dang, 2012).  
I conducted a literature review using databases accessible through the Walden 
University Library, including CINAHL Plus with Full Text, MEDLINE with Full Text, 
PubMed, Ovid Nursing, Embase, ProQuest Nursing and Allied Health Source, and 
Google Scholar. The following terms were used in the literature search: prostate, 
prostate cancer, radiation therapy, radiotherapy, simulation, bladder filling, bladder 
regimen, bladder protocol, bowel emptying, bowel regimen, bowel protocol, fiducials, 
prostate motion, clinical practice guideline, AGREE II, implanted rectal spacer, and 





comprehensive search. From the results, I completed citation chaining to ensure a 
thorough search and identify historical research. Publication years were initially limited 
to 2014–2019, but I also conducted an additional search to update any articles added in 
2020 to include all up-to-date articles. Sources of evidence were not be limited to those 
published in the United States, so spelling variation was included to account for 
international studies.   
The evidence found in the literature review helped meet the purpose of this 
doctoral project by addressing the gap in practice of no standardized process for 
implementing presimulation interventions for patients with prostate cancer undergoing 
radiation therapy. This doctoral project addresses the gap in practice by evaluating the 
quality of literature currently available on interventions to minimize prostate movement 
and reduce radiation to healthy surrounding tissue. I used the tools provided by the 
JHNEBP model to organize and guide the analysis of the evidence. The grading and 
scoring of the evidence in the literature review using the JHNEBP model is located in 
Appendix A. After evaluating the quality of the evidence, it was synthesized into a CPG. 
I maintained ethical protections during the doctoral project by following the 
Walden University (2019) Manual for Clinical Practice Guideline Development. The 
project was submitted to the Walden University Institutional Review Board and approved 
(approval number 01-02-20-0974445) before data were collected. No patient personal 





Analysis and Synthesis 
After developing the proposed guideline, the project team reviewed the guideline 
using the AGREE II instrument. The AGREE II instrument is a validated and reliable 
tool containing 23 questions, organized into six different domains, that aims to evaluate 
whether guidelines are free of bias and have been developed methodically and 
rigorously (AGREE Trust, n.d.). I revised the proposed guideline based on the panel’s 
recommendations and had them complete a second review. Once the CPG was finalized 
and the doctoral project was completed, the proposed guidelines were shared with clinic 
administration, and upon their approval, with the multidisciplinary team. 
Summary 
 In Section 3, I described the participants, procedures, and protections that 
supported this project. The process of analysis and synthesis was also presented. In 







Section 4: Findings and Recommendations 
Introduction 
Appropriate preparation and setup for prostate cancer radiation therapy can reduce 
damage to healthy tissue; however, there is a gap in practice that front-line staff has no 
standardized guidelines from the practice site or industry leaders to prepare patients for 
prostate therapy setup. The practice-focused question for this project was: What best 
practices contribute to a CPG for preparing patients with prostate cancer undergoing 
radiation therapy treatment? The purpose of this doctoral project was to address the gap 
in practice of the lack of a standardized process for implementing presimulation 
interventions for patients with prostate cancer undergoing radiation therapy by 
developing an evidence-based CPG.   
The sources of evidence used to create the CPG were primary sources that 
included translational literature, evidence summaries like systematic reviews, and expert 
opinion. I obtained evidence through a review of the literature with the publication years 
of 2014–2020 using databases accessible through the Walden University Library. 
Additional evidence was added to the results by citation chaining to ensure a thorough 
search. I then evaluated the results using the JHNEBP model for evidence level and 
quality of the study. Recommendations for inclusion in the CPG were considered based 
on quantity, quality, the patient feedback reported in the studies, financial impact, and 





Findings and Implications 
The project team reviewed and analyzed the CPG for validity using the AGREE II 
instrument. I used the AGREE II instrument instructions to score the CPG based on the 
project team’s evaluation. Each project team member, when asked to participate in the 
project, was introduced to the concept of the AGREE II method. After developing the 
CPG, I reviewed the AGREE II instrument with each team member and gave them each a 
copy of the AGREE II instrument, the CPG, and the literature review. The project team 
members were to return their completed AGREE II tools within 1.5 weeks; however only 
1 of the 3 finished it in that period. Two team members needed an additional 2.5 weeks to 
complete the AGREE II instrument. Two of the project team members supplied 
comments in addition to their scores of the questions, and the third team member made 
no comments. The individual reviewers’ scores are presented in Table 1.  
The AGREE II instrument contains 23 questions, organized into six different 
domains, followed by two items that assess the overall score and recommendation for 
using the CPG evaluated (AGREE Research Trust, n.d.). Each item within the domains 
are rated as 1 (strongly disagree) to 7 (strongly agree). However, scoring is represented 
as a percentage by each domain and is calculated by totaling the obtained score: The 
minimum possible score over the maximum possible score for the domain minus the 
minimum possible score ( Brouwers et al., 2010). Overall, the expert panel recommended 








Results of the AGREE Instrument Provided by the Expert Project Team 
Domain Expert 1 Expert 2 Expert 3 
Domain 1    
Item 1 7 3 6 
Item 2 7 4 7 
Item 3 7 7 7 
Domain 2    
Item 1 7 4 5 
Item 2 5 3 5 
Item 3 6 7 7 
Domain 3    
Item 1 7 7 7 
Item 2 6 7 6 
Item 3 7 7 7 
Item 4 6 7 7 
Item 5 5 7 6 
Item 6 6 7 6 
Item 7 5 6 6 
Domain 4    
Item 1 7 6 6 
Item 2 6 7 7 
Item 3 7 7 7 
Domain 5    
Item 1 5 6 7 
Item 2 6 7 7 
Item 3 4 3 5 
Item 4 4 2 6 
Domain 6    
Item 1 7 7 7 
Item 2 6 7 5 
Total 52 52 57 
Overall Guideline Assessment 
Item 1 6 6 6 










Domain 1 of the AGREE II instrument focuses on identifying the robustness of 
the scope and purpose of the CPG (Brouwers et al., 2010). This section has three 
questions, and the project team scored Domain 1 as 85.19% overall. One reviewer asked 
for a clarifying comment about the goals of the CPG. During the review process, the 
project team members’ answers were blinded to me; however, the nurse team member 
followed up after submitting her responses to state that she understood the goal of the 
CPG but was seeking more clarification on the downstream effects of the implementation 
of the CPG.  
Domain 2 
 Domain 2 of the AGREE II instrument focuses on identifying the extent of 
stakeholder involvement (Brouwers et al., 2010). This section also has three questions; 
the overall score for Domain 2 in this project was 74.07%. One area of improvement 
noted was that the views of the target population had been obtained through the literature 
review findings and that there were limitations within the studies used to develop the 
CPG.  
Domain 3 
 Domain 3 of the AGREE II instrument concentrates on the rigor of developing the 
CPG (Brouwers et al., 2010). This section contains eight questions; however, one 
question was excluded in this project as the CPG lacked a procedure for updating the 





appropriate procedure and frequency for updating the CPG. The overall score for Domain 
3 was 90.48%. Comments in this section reflected that the reviewers observed the 
recommendations were clear and based on the literature review.  
Domain 4 
 Domain 4 of the AGREE II instrument sought to identify the clarity of the 
recommendations and management presentation (Brouwers et al., 2010).  Domain 4 
comprised three questions and was the highest-scoring domain from the reviewers at 
94.44%. The project team commented that the recommendations were clear and specific, 
and key recommendations were easy to read in the table format.  
Domain 5 
 Domain 5 of the AGREE II instrument assesses the applicability of the CPG to 
practice, and there are four questions in this domain (Brouwers et al., 2010). The overall 
score for this domain was 69.45%. The project team made comments in the AGREE II 
instrument of additional barriers, such as cost information that the CPG did not address. 
The project team also pointed out that there was a lack of description of how users would 
measure the CPG as successful.  
Domain 6 
 Domain 6 of the AGREE II instrument focused on assuring there was editorial 
independence in that the CPG was free from competing interests or those interests were 





80.49%. The reviewers commented that it was clearly stated that there were no 
competing interests from funding bodies.  
Overall Guideline Assessment 
The overall guideline assessment section in the AGREE II instrument is 
comprised of two questions (Brouwers et al., 2010). The first question was to rate the 
overall quality of this guideline on a scale of 1 (lowest possible quality) to 7 (highest 
possible quality), and the reviewers unanimously scored this question a 6 out of 7. The 
second question was “I would recommend this guideline for use.” Reviewers could 
choose: yes; yes, with modifications; or no. One reviewer chose yes, while the other two 
chose yes, with modifications. No reviewers added notes or comments in the overall 
guideline assessment section.  
One area outside the scope of the development of this CPG was updating the 
CPG. When a final determination for long-term ownership of the CPG is made, the 
procedure will be added based on that organization’s practices. Another limitation was 
the lack of cost analysis in the literature review on the various interventions guiding the 
recommendations; this limitation was reflected in the project team’s scoring. 
The CPG analysis shows that there are EBPs to develop a CPG to guide radiation 
oncology healthcare workers to choose more appropriate interventions to improve the 
planning session for prostate radiation therapy. This can positively impact individual 
patients by improving their therapy planning session, the population of radiation 





the workflow to the point of cost avoidance. The potential implication for positive social 
change is that by making this CPG available through publication, easy-to-use, evidence-
based interventions would be made available to patients worldwide, from small, 
generalized radiation clinics to large, highly specialized academic institutions.  
Recommendations 
Within the CPG, recommendations are broken down into four categories: bladder 
management, bowel management, imaging/treatment quality, and patient education. By 
implementing these practice guidelines, radiation oncology practitioners have a 
standardized tool that they can use to inform interventions for every patient’s 
presimulation. Additionally, the CPG provides secondary recommendations, which may 
be used for patients who need additional interventions and should not be considered for 
every patient. 
  Bladder management interventions had the widest variety of practices in the 
literature; however, the recommendations that were made in the CPG had some of the 
strongest studies supporting the findings. Recommendations include having the patient 
empty their bladder, then drink 500 mL of water finishing 60 minutes before the 
simulation/treatment (see Maggio et al., 2017, Nathoo et al., 2018; Holden, Stanford, 
D’Alimonte, Kiss, & Loblaw, 2014). Fujioka et al.’s (2016) findings informed the 
recommendation that a goal bladder volume on ultrasound is between 100 mL and 250 
mL at the time of the simulation. The final recommendation for bladder management is 





(see Oates et al., 2014; Smitsmans et al., 2017; Sunshine Coast Hospital, 2017; Yaver et 
al., 2015). Bladder management is one category of interventions for presimulation for 
patients with prostate cancer. Another important category is bowel management.  
Proper bowel management helps keep the bowel away from the area receiving 
radiation for patients receiving prostate radiation (Yaver et al., 2015). Specifically, 
patients should have an empty rectum for treatment; to accomplish this, they should have 
a bowel movement daily and pass flatulence 1 to 2 hours before treatment (Maggio et al., 
2017; Rogel Cancer Center, 2016). Patients should eat an antiflatulence diet by avoiding 
fermentable carbohydrates, carbonated beverages, dairy, and high-fat foods (Cancer 
Center of Santa Barbara, 2017; Hosni et al., 2017; Oates et al., 2014; Smitsmans et al., 
2017). Patients should also change their eating style to improve gas management; they 
can do this by reducing aerophagia (i.e., excessive and repetitive air swallowing; Cancer 
Center of Santa Barbara, 2017; Oates et al., 2014; Smitsmans et al., 2017; Sunshine Coast 
Hospital, 2017). Additional steps for bowel management include taking an osmolotic 
laxative nightly, starting 5 days before simulation, and continuing throughout treatment 
and reducing as needed for excessive stools (Bayles, 2015; Sunshine Coast Hospital, 
2017; Weston, 2019). Take a Fleet enema if unsuccessful with other interventions to have 
a bowel movement daily, or if the rectum is greater than 3.5 cm on simulation CT 
(McNair et al., 2011Memorial Sloan Kettering Cancer Center, 2018). The final 
recommendation for bowel management is to increase exercise daily to promote bowel 





addition to bowel and bladder recommendations for patients, there are imaging/treatment 
recommendations and patient education recommendations that radiation therapy teams 
can use to help patients be successful with simulation.  
  A recommendation to improve imaging quality is to give patients consistent 
appointment times; this allows them to get into a routine and have them set up the same 
(see Yaver et al., 2015). Providers can also consider the use of interstitial biodegradable 
balloons (i.e., hydrogel spacers); when hydrogel spaces are used, they should be injected 
at least 3–5 days before the patient is simulated (Uhl et al., 2013). As techniques 
improve, there is still a basic human connection between patients and providers, and 
patient education has an important role in preparing patients for their simulation.  
  Radiation oncology staff should provide verbal and written specialized patient 
education to patients (McGuffin et al., 2018). Whenever possible, add appropriate images 
to patient education; customizing the images to the treatment center will help patients 
associate what they were taught and may help them feel more comfortable (Osmar & 
Webb, 2015). When providing education, radiation oncology staff should speak with 
plain language, use analogies, and repeat information; if patients need clarity, direct them 
to a radiation oncologist, and confirm the patient’s understanding with the teach-back 
method (Schnitzler et al., 2017). The full CPG is located in Appendix B for reference.  
Contribution of the Doctoral Project Team 
At the start of the project, the doctoral project team was contacted about 





director, a primary prostate cancer radiation oncology nurse, and a prostate radiation 
oncologist. Project team members informed me of potential interventions/keywords to 
include in the literature review when searching for best practices based on discipline-
specific interventions. At the start of the project, the intention was to have the team meet 
in person; however, limitations imposed by COVID-19 and team member schedules 
prevented this, and I met individually with team members regarding the project. After I 
completed the literature review and grading of the articles using the JHNEBP model, 
individual meetings with the project team members occurred to review findings and 
identify potential recommendations based on quality and frequency of evidence. After the 
CPG was developed, the project team assessed the CPG with the AGREE II instrument 
for validity. The prostate expert physician team member verbalized the importance of the 
CPG and DNP project findings. He noted that he felt for radiation oncology professional 
organizations to accept the CPG, the CPG would have to have more depth, and the 
current version of the CPG would be a good summary for the overall CPG to be 
published.  
After the DNP doctoral project, the project site and project team members have 
expressed interest in researching the CPG recommendations. The team would like to 
compare the standard of care (no defined interventions) and the application of the CPG 
recommendation. They propose measuring success by evaluating the frequency patients 
undergoing radiation for prostate cancer need to have cone-beam CT images before 





based on the literature review and findings from primary sources such as financial 
implications. They also recommended engaging a focus group, which is outside of the 
scope of this DNP project.   
Strengths and Limitations of the Project 
This doctoral project had several strengths as well as limitations. Strengths 
included project site support, from front-line staff to the department chairperson staff at 
this project site, recognizing the problem addressed in the project, and supporting the 
effort to address it. Additionally, there was a sufficient of literature to help answer the 
project focus of what best practices contribute to a CPG for setting up patients with 
prostate cancer undergoing radiation therapy treatment. Strengths and limitations of the 
project include the project team; the team was able to give different viewpoints about the 
gap-in-practice. Nevertheless, a delay in the project occurred during the literature review 
phase when I was the only team member who knew the grading and scoring for literature 
using the JHNEBP model.  
Recommendations for future CPG development projects include having a 
moderate-sized interdisciplinary project team. Additionally, consider using mind 
mapping to help organize recommendations from the literature review. Finally, for topics 
that seem to have limited research available, citation chaining helps identify additional 





Section 5: Dissemination Plan 
Introduction 
The first step in the plan to disseminate this CPG to the institution experiencing 
this practice problem is to present this to the leadership team. Simultaneously, I plan to 
present the CPG to the nurses supporting patients receiving prostate radiation and their 
providers. Many team members may ask for the supporting information for the CPG, so it 
will be important to have the literature review grid available and the references to the full 
articles that informed the recommendations. The intended audience is a relatively small 
group of less than 10 individuals. To sustain the dissemination of this information to 
incoming nurses to the department, the CPG will be added to the nursing orientation 
binder.  
Radiation oncology nurses caring for patients receiving prostate cancer treatment 
are the primary audience for this CPG. Radiation oncology residents, therapists, or 
radiation oncologists may also find the CPG beneficial. The CPG would also be 
appropriate to disseminate to the Oncology Nursing Society through the national 
convention and through journal articles to reach their primary audience. Another avenue 
of dissemination could be through advanced practice nurses and their respective society 
Advanced Practitioner Society for Hematology and Oncology, journals, and conventions. 
Analysis of Self 
Reflecting on my roles while completing the doctoral project, I was able to apply 





techniques. Using these skills outside my assigned job duties helped prepare me for 
future endeavors where I may lead an organization-based team/project. The doctoral 
project was the first time I created a CPG, and I found the entire process very rewarding. 
I think providing nurses with EBPs can profoundly impact the patient, nurse, and 
organization/system.  
I had anticipated challenges with the completion of this project but nothing to the 
extent that COVID-19 presented. Initially, I had planned to take time off work to devote 
to working on the project; however, COVID-19 expanded my working hours as well as 
those of the project team. We experienced shifted job responsibilities and increased 
workloads even after the risk had seemed to level out. I had to meet with the project team 
virtually, not physically seeing some of the team members for months. This lack of a 
visual reminder of scheduled tasks also meant I had to e-mail the team to remind them to 
complete and return the completed tools. It was a good practice of holding teammates 
accountable to a timeline regardless of rank and, at times, required flexibility. 
Completing this project has given me insight into how to be a better project manager and 
that CPGs are important and useful for nurses. Additionally, I learned that with the right 
team and adequate time, developing a CPG is not that challenging. 
Summary 
Complex treatments can require complex interventions. The setup for patients 
receiving radiation for prostate cancer is complex, and currently, there are no 





are a way to provide nurses with evidence-based interventions and improve overall care 
as evidenced by improved patient outcomes, patient care, and staff satisfaction (Medves 
et al., 2010). With the support of a project team, I identified which EBPs were supported 
in the literature and then created a CPG for the preparation for patients undergoing 
radiation for prostate cancer. The project team validated this CPG using the AGREE II 
instrument. The CPG will be shared with a broader base of oncology nurses, outside of 
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Findings that help 

















   Interstitial 
biodegradable 
balloons- may not 
completely push rectal 
volume out of field, 
invasive- once, patient 
acceptable 
   Endorectal balloons 
(ERB)- may not 
complete push rectal 
volume out of field, 
may push anterior 
rectal wall into high 
dose areas despite 
reducing posterior 
rectal wall dose, 
possible interfraction 
motion due to 
presence of stool, 
























daily for treatment 
   Rectum empting 





   Polyethylene glycol- 
most effect in stool 
frequency  and 
formation and faster 
   Senna-lack of 
placebo control in 
studies 
   Enemas- 
Recommending in 
areas where use of 
CBCT is limited, used 
for short duration such 
as RT, semi-invasive, 
well-tolerated, 
complication of risk of 
mechanical injury, but 
clears rectum and can 
restore normal bowel 
function. Potential 
limit to simulation. 
Gas management 
  Rifaximini (non-
46 
 
absorbed antibiotic) – 
not recommend in 
consideration of long 
term SE of ABX, 
discontinue if patients 
are on during RT for 
prostate.  
   B-galactosidase- 
(Simethicone/pepperm
int oil) used with 
caution 
Diet 
   High fiber diet- 
effective at reducing 
prostate motion during 
RT, decrease stool, 




feeling of bloating and 
flatulence.  
   Probiotics- reduces 
radiation toxicities and 














Bladder preparation of 
600 mL water intake 
60 minutes before 
simulation with 
bladder volume 
confirmed to be 
“adequately full” 
along with a low 




>3.5cm on planning 
CT resulted in patient 
being given an enema 
with rescan) 
 
Rectal size had more 
of an impact on 
potential geographical 
misses concluded its 
more important to 
have small rectal size 
at time of simulation 
and treatments> based 
on findings now 
routinely administer 





was within 1cm 
of planned size 
only 56.2% of 
the time and 
rectum within 
1cm of planned 
size 65.8% of 
time. Of those 
times when both 
rectum and 
bladder were 
within 1cm of 
planned size, 




A bladder 2cm 
larger resulted in 
61.5% 
geographical 





to simulation.  
Used surgical clips 
as surrogate for 
prostate bed 
motion. Small 
volume of patients 
(40) resulted in 
sample of 377 
images. 1/8 of 


















Group 1 (n=13) void 
and drink 300 mL of 
liquid (not coffee or 
tea) 60 minutes before 
treatment 
Group 2 (n=16) 
maintain a 
comfortably filled 
bladder at treatment  
Both groups at 
simulation if rectum 
was >4 cm, enema 
was administered and 
new CT obtained 
Instructions were 
given verbally and 
written at time of 
consult, instructions 
were repeated verbally 
at start of treatment 
and weekly during 
treatment.  
Ultimately, the 
variation in bladder 
volume “hardly 
affected the CTV” and 
from a standpoint of 
ensuring coverage did 










assessed as SD 
for Group 1 was 
64  mL (95% Cl: 
(46, 105) and 
Group 2 was 61  
mL (95% Cl: 
(45, 94), no 
benefit to 





42% of Group 1 
prepared as 
instructed about 
50% of the time, 
approximately  
31% patients in 
Group 2 
prepared similar 
small sample size, 
did not consider 
development of 
side-effects of RT 
on ability to 
maintain bladder 
volume,  did not 
access impact of 














Expert opinion Not 
Applicable  
Empty bladder and 
rectum upon arrival- 
(15-30 minutes before 
treatment) then drink 
720-960 mL of water.  
Refrain from eating 
gas producing foods 4 
hours before treatment 
minimize gas- eat 
slowly, chew with 
mouth closed, avoid 
drinking with straws, 
avoid chewing gum 















Drink 250 mL 60 
minutes before 
treatment for full 
bladder  
bladder filling 
























Bladder volume at 
treatment planning 
aim to be >100  mL  





















2 groups – 5 patients 
taking one capsule of 
probiotics containing 




lactis Bi-07 a day (10x 
normal dose) 
5 others taking 
psyllium-based bulk-
forming laxative 
(Fyboigel tm, reckitt 
benckiser, Slough, 
UK; 3-5g/day 
psyllium husk). >start 
taking 1 packet nightly 
starting 1 week prior 













section area (p = 
0.008) and 
relative cross 
section area (p = 
0.007) compared 
to psyllium prep.  







empty bladder 30 
minutes prior to 
treatment, drink 500 
mL of water 
 





RTC 92  prostate 
patients 
IMRT 77Gy 
in 35 Fx, 
UMC 
Utrecht 
2 capsules of 250 mg 
magnesium oxide 
twice a day (total 
100mg daily) starting 
2 days before CT, 
control group of 
placebo capsules 2 
caps/twice daily 
 
Using MRI evaluated 
for >0.5cm^3 of air as 
significant amount of 
gas to cause rectal 
movement, occurred 
in less than 1degree 
and was in the 
intervention group. 
Does not recommend 
use of mag ox 
capsules daily during 
treatment to reduce 

























RT (78 Gy 
in 38 Fx)  
At time of simulation 
patients were asked to 
maintain a 
comfortably full 
bladder and then for 
treatments. Patients 
were preloaded with 
either 250 mL or 500 
mL of water, had their 
bladders measured and 
when bladder scanned 
volume was 180 mL 
preceded with 
treatment.  
Serum Creatinine had 
no significant 
correlation with the 
time to achieve 
bladder volume of 180 
mL.  
After treatment, 




were not able to 
achieve a 
bladder volume 
of 180 mL, d/t 
urgency or 
insufficient 
filling by 120 
minutes. Group 
1 (250 mL) 
average bladder 
fill to 180 mL 
was 64 minutes. 
Group 2 (500 
mL) average 
bladder fill to 
180 mL was 46 
minutes (p = 
0.03). The time 
for 95% of 
patients to reach 
the volume of 
180 mL was 75 


























group 2 diet 
only 
Group 1 Antiflatuance 
Diet + Milk of 
Magnesia starting 3 
days before planning 
CT, continuing 
through treatment. 
Milk of Magnesia 
initial once a day 
(bedtime 30cm3, 
adjusted 15-60 cm3 to 
achieve a soft BM in 
AM and stop with 
lower GI toxicity- 
graded with RTOG 
acuity toxicity.  
Group 2 Antiflatuance 
Diet only starting 3 
days before planning 
CT, continuing 
through treatment 
40% of Group 1 
patients stopped 
taking Milk of 
Magnesia by last 
week d/t 
toxicity. G2 
diarrhea in G1 3 
patients (7.5%) 
vs. 2 patients 
(5%) and G1 
diarrhea 21 
patients (52.5%) 
vs 7 patients 
(17.5%), with 
onset reported as 
early as week 2 
of treatment for 

































preparation to empty 
rectum and 
comfortably full 
bladder by drinking 
500  mL of water 1 
hour before planning 
CT scan and before 




























cohorts of cancer 






NRBP 125.9 +\- 


















Education on bowel 
and bladder prep 
process 
empty bladder and 
bowels before 
drinking 500  mL of 
water 30 minutes 
before appointment 
Intervention arm take 
one 80-mg pill or 
chewable 
ovol(simethicone) 
tablet twice per day 
for 2 days before CT 
simulation, 2 days 
before first treatment 
and then continuously 
throughout the course 
of treatment. 
On first day of 
treatment radiation 
therapist provided new 
The addition of 
antiflatulent 
medication to 
the bowel prep 





overall the study 
participants had 
less CT rescans 




may be in part to 
the specialized 
education that 
was prepared to 
educate patients 
on bowel and 







patient teaching and 
confirmed compliance 
with bowel bladder 
and intervention, 









how to achieve 
an empty rectum 













Oral and IV 
medication- some 
effectiveness with 
diet, laxatives and 
scheduling, no 
effectiveness (adverse 
effect) with Milk of 
Magnesia 
Diet- in studies with 
just dietary advice 
there was no 
significant or 
clinically relevant 
findings with high 
fiber or anti flatulent 
diets 
Probiotics- positive 
result in rectal volume 
but did lead to rectal 






in rectal volume and 
corresponding prostate 
motion, 1 technique 
was inserting an index 
finger into the rectal 
canal and flushing 
with water and another 
used a rectal emptying 
tube 
Enemas- 5 studies 
with enemas found 
some reduction of 
rectal volume of 
prostate motion 
15 MSK (n.d.) Expert opinion Not 
Applicable  
Marker Placement- 
Fiducial or beacon 
transponders 
Starting 7 days before 
simulation take 1 
rounded teaspoon of 
psyllium powder in 8 
oz. of water, do daily  
Day of simulation do a 
fleet enema 3 hours 
before simulation  
Use plastic mold to 
help with positioning 

















Ravi (2018)  
Void before 
simulation given 500 
mL of fluids to drink 
over 5-10 minutes. 
Ultrasound 
measurements 
obtained in 15-minute 
intervals for up to 4 
measurements before 
sim. On treatment 
patients voided, drank 
500 mL and measured 
a single time, typically 
30 minutes after 
voiding.  
 
Optimal bladder filling 
was 60 minutes after 
voiding and drinking 
500 mL of water. 
Adding ultrasound 
increased demand on 




occurred in the 
AP direction; 
bladder volume 
was on average 
larger 0.5 cm 
larger on 
treatment. No 
patients had to 







at improving the 
reproducibility 





set without the US 
intervention. No 




filling on machine 
result.  
IIA 
17 NHS (n.d.) Expert opinion Not 
Applicable  
 Drink water 
(unspecified 
amount) do not 
advise fruit 

















bladder and bowel 
prep- consume 750 
mL of water 30 
minutes before 
treatment and take 
5g/d Fybogel if 





psyllium 20 g/d + at 
least 2 L of water; and 
antiflatulant diet 
(avoid excessive dairy, 
hot/spicy foods, 
skins/stems of fruits 
and veggies, eat 
cooked veggies warm. 
Reduce fat intake (can 
delay the transmission 





chewing gum) and 







arm for rectal 
filling with a the 
center with 
while empty and 
with gas and 
feces. It suggests 






and a larger 
study should be 
completed with 
at least 50 
enrolled in each 
arm.  




Empty bowel and 
bladder 50 minutes 
before treatment drink 
750 mL water from 45 
minute to 0 minutes 
before treatment and 
to hold bladder full 
until treatment 
complete. If patients 
were felt to have gas, 
they were encouraged 
to expel the gas.  
Also, avoid caffeine 
for the two hours 
before treatment.  
Complete diet diary 
for the two weeks 
prior to CT simulation 
until the end of 
treatment.  











Created a images only 
picture book to help 



























empty bladder, then 
drink 400-600 mL 




same bladder protocol 
+ bladder ultrasound. 
No rectal empty or 
dietary advice given 
expect all patients 
encouraged to empty 
bowels before each 
treatment 
 
only 1/3 of patients 
were able to obtain the 
goal of >200cm3 for 
simulation.  
 
There was no 
correlation between 
bladder or rectal 
volumes and treatment 
IPSS scores. S 
Bladders that 
were filled to 










Limited to short 

















empty bladder, drink 
600-700 mL 60 
minutes before 
simulation and each 
treatment. Rectal 
enema before 










that the spacer 
helped limit 
dose to rectal 






allowed for dose 
escalation.  




Expert opinion Not 
Applicable  
Hydrate a few days 
before hand (drink at 
least 6 cups of water a 
day) 
Between 75- 60 
minutes before 
simulation/treatment, 
empty bladder then 
drink 600  mL water 
Have BM within 4 
hours of simulation 
and radiation 
treatment 
  VB 
63 
 
Pass flatus 1 hour 
before 
simulation/treatment 
Inform nursing staff if 















had prior RT 
Teachings contained 
medical (specialized 
words) and contextual 
(common words used 
differently in relation 
to treatment) jargon 






explanation, use of 
analogies and plain 
language, visual tools, 
and repetition of 
information. Use 
empathy when 
responding and refer 
to Radiation 
Oncologist when 
unable to answer 
question. Confirm 
understanding with 







was presented to. 
Single encounter, 
audio reorderings 
only a small part 
of the education 
process, being 
aware of audio 

















full bladder by 
drinking 250  mL of 
liquid 60 minutes 
before simulation and 
treatment and empty 
bowel. 
Dietary intervention- 
standard treatment and 
starting 1 week before 
simulation until end of 
treatment eat regularly 
(no skipping meals), 
drink 1.5-2 L liquid 
per day, and increase 
physical activity. 
Avoid food: whole 













Within the DI 
group there was 
greater success 
(p < 0.001) in 
scans acquired 




the success rate 
Changes in CT 
imaging protocols 










bananas, prunes, dried 
fruits), hot and spicy 
foods, carbonated 
beverages, more than 
>4 cups of coffee per 
day; avoid swallowing 
air by eat slowly and 
chew food well, chew 
with your mouth 
closed, avoid chewing 
gum, sip beverages. 
Take 2 tablets of Mag 
Oxide 500mg per 
night starting 2 nights 
before simulation, and 
then 2 nights 
continually through 
treatment at same time 
daily; treatments 
scheduled after 10am. 
was lower in 
treatment scans 
acquired before 







Expert opinion Not 
Applicable  
Fluid bladder and 
empty rectum. 
Hydrate with at least 
1.5 L fluid (preferred 
water) daily. 
Take ClearLax or 
Movicol daily, starting 
5 days before planning 
simulation. 
Reduce gas formation 
by: eat slowly, chew 
food well with mouth 
closed, avoid skipping 
meals, sip fluids, 




On day of planning, 
and drink 600 mL of 
water 30-40 minutes 
before scan.  
  VC 
67 
 
















Score ≤7, no 
nodes 
treated.  
Full bladder protocol, 
void bowel and 
bladder then 45 
minutes to the start of 
CT simulation drink 
300  mL of water 
within 15 minutes.  
No bladder protocol 
given for intervention 
group. 




due to bladder 




there was no 
significant 
difference GI 




grade 3 or 4 
toxicities.  
small sample size IIB 













Injection of hydrogel 
spacer had 3-5 days 
later had simulation 
scan, received 78 Gy. 
12% of patients 
experienced 
grade 2 GI 
toxicity. No 
stage 3 or 4 
toxicities 
reported in acute 
toxicity. In late 
toxicity, only 
7% of patients 
reported grade 1 
GI toxicity no 2, 







3, or 4.  



































groups. Dose of 
V75GY was 
significantly 



























+IRS and -IRS 
group favoring 
+IRS p=,0.001, 
as well as 3year 
grade 2-3 lower 
rectal bleeding 
<0.0001 and 3 
year grade 3 
lower rectal 
bleeding <0.002 
as well as 
chronic grade 2-
3 late fecal 
incontinence 
0.006.  





















All patients received 
same bowel and 
bladder prep including 
dietary guidelines, 
anti=gas tablets, and 
before planning CT 
were instructed to self-
administer two Fleets 
enemas, 1 hour apart.  
 
Daily, patients were 
instructed to empty 






cm3) (small) to 





twice as likely to 
experience twice 
bladder filling was 
not measured and 
can effect prostate 
motion, small 







a consume 500 mL of 
water 20-30 minutes 
before treatment.  
The patient was 
positioned supine, 
with an indexed knee 
wedge, foot lock, and 
lumen 100 mL water-
filled endorectal 
balloon. Patients 




The study found that 
100 mL water filled 
balloon may not be 
large enough to 
immobilize the 
prostate in rectums 
with large gas/stool 
volumes- 76% of 
images showed 
stool/gas volume less 
than 30 mL with 90% 
of total images 
revealing stool/gas 
volume less than 10 
mL.  
as much prostate 
movement in the 






















of 10 g soluble fiber 





3350 6.563 g) 
both low gas diet (low 
in fermentable carbs, 
gastric irritants, and 
carbonated beverages) 
provided by dietitian 













of gas levels, 
limited external 
validity, probiotic 
only in IG group 
IB 
















Cohort 1- (Laxative) - 
fleets enema the 
morning of simulation 
planning, Milk of 
Magnesia daily during 
treatments 
Cohort 2 (consistent 
timing) - appointment 
times aligned with 
There was no 
difference 
between the two 
cohorts in gas 
volume, rectal 
volume, bladder 
volume in PTV, 
rectal volume in 













natural bowel habits, 




patients with no 
preexisting urinary 
conditions were 
instructed to drink 2L 
water daily before 
simulation and during 
treatment  
 
All patients instructed 
to drink 250 mL water 
60 minutes before 





















Appendix B: Interventions to Prepare a Patient With Prostate Cancer for External Beam 
Radiation Therapy  
Introduction 
The intent of this clinical practice guideline is to provide guidance for radiation 
oncology healthcare to choose more appropriate and achievable interventions (Institute of 
Medicine, 2011). Specifically, this guideline will aim to help improve the planning 
session for prostate radiation therapy as it relates to modifiable factors such as bladder 
management, bowel management, and image quality. Patients that are the target 
population of this CPG are males, with localized prostate cancer, planned to receive 
intensity modulated radiation therapy (IMRT). Providers may consider these guidelines 
for other radiation treatments such as hypofractionated treatment and proton radiation 
however, the sources of evidence were primarily IMRT studies and that consideration 
should be made when applying the CPG outside of this population. Patients who prior to 
starting radiation therapy have challenges with bowel management or known dietary/fluid 
restrictions may need to be recommended a modified version of the clinical practice 
guideline and healthcare providers should consider consulting a nutritionist for 
assistance. 
Formulating the recommendations  
A literature review was conducted using CINAHL Plus with Full Text, MEDLINE 
with Full Text, PubMed, Ovid Nursing, Embase, ProQuest Nursing and Allied Health 
Source, and Google Scholar. The following terms were used in the literature search: 
prostate, prostate cancer, radiation therapy, radiotherapy, simulation, bladder filling, 
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bladder regimen, bladder protocol, bowel emptying, bowel regimen, bowel protocol, 
fiducials, prostate motion, clinical practice guideline, AGREE II, implanted rectal 
spacer, and hydrogel. Additionally, the Boolean strings and/or were used to obtain a 
more comprehensive search. Abstracts were reviewed to identify articles that best 
appeared to match the practice question, 62 articles were identified. Publication years 
were limited to 2014-2019 initially, an additional search to update any articles that added 
providers (MDs, advanced care practitioners, registered nurses, radiation therapists) to 
prepare patients with prostate cancer for radiation therapy planning session and treatment. 
The expected benefit of having clinical practice guidelines improve equity of care, reduce 
variations in care, assist in social change, and aim to define best practices in healthcare. 
CPGs allow the provider to identify barriers and thus choose more appropriate and 
achievable interventions. 
The initial literature review had publication years limited to 2014-2019 initially, so an 
additional search in the summer of 2020 was conducted to ensure all up to date articles 
were included; historical research were identified through the citation chaining methods. 
Sources of evidence were not be limited to those published in the US so spelling variation 
was included to account for international studies. A final 31 sources of evidence were 
used to inform the CPG.  
After evidence is acquired through the literature review, it is evaluated for level and 
quality using the Johns Hopkins Nursing Evidence Based Practice (JHNEBP) model. The 
JHNEBP is used to evaluate the level and quality of each evidence source, then 
summarize the evidence, and synthesize the collective evidence for quality and strength 
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(Dearholt & Dang, 2012). In the JHNEBP model evidence is leveled based on the source 
or evidence ranging from I-V including both research and non-research forms of 
evidence, then the evidence is rated based on quality; evidence may receive a score of A 
for high quality, B for good quality, and C for low quality or major flaws within the 
evidence. Based on the JHNEBP evidence from all types of sources can be considered, 
this allows for includes of internal and external forces when considering the application 
of identified best practices which is helpful in the development of a practical CPG. The 
evidence selected that informed this CPG was based on the reported outcomes, quality, 
level, frequency, ability to implement, and patient tolerability.  
Clinical Practice Guideline Recommendations 
Primary recommendations 





Empty bladder then drink 500 mL of water 
finishing 6o minutes before simulation/treatment 
IIA  
Goal bladder volume via ultra sound of >100 mL 
and <250 mL at the time of simulation 
IIB  
Consume at least 1.5L- 2L water daily  IB   
Bowel Management  
 
Patient should have an empty rectum for treatment, 
to do this they should strive to have a bowel 
movement daily before treatment and should pass 
flatulence 1-2 hours before treatment.  
IIA  
Gas Management (Diet)- 
Provide education and recommend an antiflatulance 
diet: avoid fermentable carbohydrates including 
lentils, beans, peas, broccoli, cauliflower, Brussel 
sprouts, cabbage, sauerkraut, cucumber, turnip, 
onions, garlic, apples, bananas, carbonated 
beverages, dairy, high-fat foods. 
IIA  
Gas Management (Eating Style) - Reduce 
aerophagia (excessive and repetitive air 




eat slowly, and chew food well. Do not use chewing 
gum, avoid using straws if able, and sip beverages. 
Recommend osmolotic laxative, nightly starting 5 
days before simulation and continue through 
treatment, reduce as need for excessive stools. 
IB 
Recommend Fleet® enema if unsuccessful with 
other interventions and/or rectum is greater than 
>3.5 cm on simulation CT. 
IIIB  






Give patients consistent appointment times that 
align with their daily bowel habits. 
IIA  
Interstitial biodegradable balloons (hydrogel 






Provide verbal and written specialized patient 
education. 
IB  
Add images to patient education. IIIB  
Use analogies, plain language, repeat information. 
Refer to radiation oncologist when unable to answer 
a patient’s direct question. Confirm patient’s 
understanding with the use of teach back method.  
IIIB  
Secondary recommendations- 
 Magnesium-several studies found no benefit of the addition of magnesium (Milk 
of magnesium or magnesium tablets) for bowel management on a routine basis. 
One study found that most patients stopped taking routine Milk of Magnesium 
due to GI toxicity before the end of treatment.  
 Rectal emptying tube is not recommended related to possible incorrect 
placement and invasive nature, as well as repeated need for each treatment.  
 Rectal balloon- patients that receive rectal balloons instead of interstitial 
biodegradable balloons may need >100cc volume instilled if they experience 
larger rectal gas volumes to reduce prostate motion.  
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 Probiotics- daily probiotics had conflicting evidence and no recommendations 
can be made without further studies on the impact of daily probiotics on prostate 
radiation side effects or bowel management for prostate radiation.  
 Gas management- 
o Rifaximini, a non-absorbed antibiotic, is not advised for use during 
radiation treatment of prostate cancer and should be discontinued if 
patients are one prior to treatment.  
o Simethicone/peppermint oil, should be used with caution and were not 
shown to have statistical or clinical significance when added as 
preventative management for gas management.  
Strengths within the body of evidence include obtaining patient feedback on 
interventions were taken into consideration when developing the recommendations, the 
large number of sources of evidence often addressed several aspects areas within the 
recommendations allowing for multilayered support of the recommendations put forward. 
The limitations within the body of evidence include inconsistent definitions between 
studies, studies having small sample sizes, lacking control, and limited randomized 
control trials. Additional limitations include advancements of, and variations in, radiation 
therapy administration between the bodies of evidence, which had potential impact on the 
patient experience during the studies that informed the evidence.  
